AAD Member

10/15/2026

Guess where you will be next March 19-23? That's right...San Francisco! 😍

Join us at the Annual Meeting, where education and community bridge together at the world’s largest dermatology conference.

Registration opens Nov. 18 for Physician, Life, and Honorary AAD members and
Nov. 24 for all other categories.

Learn more and start planning your trip to the Bay with the AAD at aad.org/am27.

The 2027 AAD Annual Meeting is scheduled to take place March 19-23, 2027, in San Francisco, California, bringing you the latest developments in the field and the opportunities to connect with the best in dermatology.

10/12/2026

AAD member dermatologists 📢 Register now to join our next Advocacy Town Hall on Oct. 13 at 6 p.m. (CT) with President Dr. Murad Alam.

Hear updates on the Academy’s response to the proposed Medicare cuts and what our plans are to save dermatological care for skin cancer patients.

10/04/2026

An article published in established consensus-driven practical recommendations for acute treatment and long-term maintenance of seborrheic dermatitis (SD). Using the Delphi method, 33 dermatology experts reached consensus on 44 statements.

The consensus prioritized combination therapy with topical antifungals and anti-inflammatory agents for acute flares and long-term maintenance. There were 11 consensus statements for first-line scalp treatments for short-term control, including antifungal shampoos with azole derivatives; ciclopirosolamine/piroxolamine; and topical corticosteroids, among others.

For long-term maintenance of scalp SD, experts agreed on topical antifungals and steroid-sparing topical calcineurin inhibitors (tacrolimus/pimecrolimus) as maintenance options. The panel also strongly endorsed a strategy where more potent agents are used during flares with a transition to safer options for remission, to optimize long-term control while minimizing adverse effects.

For extensive or refractory cases, the consensus provided a structured framework for escalating to systemic treatments like low-dose isotretinoin or oral antifungals like itraconazole.

Visit the link in our bio to learn more in the AAD's .

10/01/2026

📢 90,158 signers to date. Will you help us get to 100,000?

Every signature strengthens our voice in Washington. Add your name to support our Community Statement and ensure our seniors retain access to timely skin cancer care with their dermatologists!

➡️ Sign now at: saveskincancercare.org

09/30/2026

AADA President Dr. Murad Alam describes our recent work in Washington, D.C. and our fight for legislation to tie physician payments to inflation.

See what you can do to take action! ➡️ https://www.aad.org/member/advocacy

09/28/2026

We need your help! Please sign our Community Statement at www.saveskincancercare.org!

09/27/2026

📢 The American Academy of Dermatology is now accepting applications for Assistant Secretary-Treasurer.

In this Academy Insider interview, our three most recent Secretary-Treasurers — Keyvan Nouri, MD, MBA, FAAD; Daniel D. Bennett, MD, FAAD; and Marta Van Beek, MD, MPH, FAAD — share insights on the role, how it impacted their careers, and the qualities that make a strong candidate.

Learn more about this leadership opportunity and hear their advice for prospective applicants at the link below.

➡️ https://www.aad.org/dw/insider/assistant-secretary-treasurer

09/23/2026

Last week, dermatologists, resident scholars, patient advocates, and other attendees joined the AADA in Washington, D.C., to advocate to Congress and urge them to contact CMS about the proposed changes to the 2027 Medicare Physician Fee Schedule.

Attendees met with their Congresspeople on Capitol Hill to oppose the proposed 50% same-day Evaluation and Management (E/M) reduction (known as modifier 25) and to pause indirect practice expense changes prior to finalizing the 2027 Fee Schedule.

This advocacy was in conjunction with our continuing work towards long-term Medicare physician payment reform.

If you were not able to join us, we ask that you do your part and sign our Community Statement to help us Save Skin Cancer Care! ➡️ www.saveskincancercare.org